Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Warrants

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Oct 20, 2020 3:23pm

193 Views

Post# 31749351

RE:RE:Warrants

Canadafan,

You have been a cheerleader for this company for a very long time, posting under a number of different aliases on several message boards. Do you get paid by the number of words or the number of posts?

Not once have you posted anything of substance. Your primary objective has always been to lure naive investors and pump up the SP.

<< Previous

Bullboard Posts

Next >>

Why this low-cost natural gas stock is missing in your portfolio